This report provides an overview of the key information gaps and limitations in interpreting existing COVID-19 data
CBR Advisory Working Group | Co-ordinator: Karen Heinicke-Motsch
Advocacy report March 2011
303100 03/2011 E 1,000
· Relevant interventions
· HIV country profiles
· Adolescents country profiles
Panam Salud Publica. 2021;45:e22. https://doi.org/10.26633/RPSP.2021.22
J Pharm Pharm Sci (www.cspsCanada.org) 16(3) 441 - 455, 2013
Virtual MentorAmerican Medical Association Journal of Ethics May 2007, Volume 9, Number 5:384-387
BUKO Pharma-Kampagne has investigated the causes and consequences of antibiotic resistance in India, South Africa, Tanzania and Germany. Together with our partners we collected data and did interviews with numerous stakeholders. The outcome is presented in a brochure that is now available in English...
Resistant bacteria are spreading worldwide. In collaboration with partners in India, Tanzania, South Africa and Germany, we have investigated the causes and consequences of this spread.2 This Pharma-Brief Special presents the results. It examines the risks for humans, animals and the environment. It focuses on local problems and approaches, international interactions and the re-sponsibility of doctors, farmers and consumers.
more
January – December 2014
Republic of Moldova South‐East European Region National Coordination Council
Declaration of Commitment of the United Nations General Assembly Special Session on HIV/AIDS
Handbook of Foodborne Pathogenic Microorganisms and Natural Toxins
ECDC MISSION REPORT 19–21 September 2016 ; 14–15 November 2016